Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…tremities (71% knees), and 1 facial lesion. Treatments included prednisone (76%), mycophenolate mofetil (64%), endothelin receptor antagon…
… AHSCT after failing standard therapies including methotrexate, mycophenolate mofetil, cyclophosphamide, and rituximab. The conditioning regimen cons…
…9%/3.0% and 2.0%/3.9%/0% of patients receiving fipaxalparant QD/fipaxalparant BID/placebo, respectively. No patients met Hy’s law.Conclusions…
…e most prescribed IS in ACA- (47%), mainly for ILD (82%), while methotrexate (MTX) predominated in ACA+ (53%), used for cutaneous (44%) or a…
…n TCZ monotherapy, the most common combination therapy was with methotrexate(35%). In SSc-ILD patients, a significant decline of %pFVC from …
…nt systemic treatment in both LS (67.9%) and SSc (48%). In SSc, mycophenolate mofetil (38.1%) and cyclophosphamide (14.1%) were also commonly used. B…
…itiated for uveitis and SSc-related manifestations, followed by upadacitinib to address AS activity and potential benefit for SSc. After thr…
…es ANA, anti-Sm and anti-RO 52 were positive. Antimalarials and prednisone were started. One year later, her physical examination showed d…
…uffy hands, telangiectasias, ANA positive. She was treated with methotrexate . Over the course of the disease she developed digital ulcers, …
…LR3 (19% vs 8%; p=0.03).Subsequent cancers were associated with cyclophosphamide (OR 2.6; CI 1.5-4.7), negatively with mycophenolate (OR 0.4; CI…
…er distances. Similarly, access to multiple immunosuppressants (cyclophosphamide, azathioprine, methotrexate, tocilizumab) and vasoactive/vasodi…
…ty over 3 months compared with NSAIDs, with the improvement for baricitinib reaching statistical significance. Over 12 months, disease acti…